NSP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Insperity Inc (NSP) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive catalysts like insider and hedge fund buying, the financial performance and mixed analyst ratings suggest caution. The technical indicators and options data do not provide a compelling entry point for immediate investment.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 66.354, and moving averages are converging, suggesting no clear trend. Key support and resistance levels are at S1: 25.329 and R1: 28.943, with the current pre-market price at 28.81, near resistance.
Insider buying has surged by 4726.40% in the last month, and hedge fund buying has increased by 247.65% over the last quarter. These trends indicate confidence from key stakeholders.
Analyst ratings are mixed, with lowered price targets and concerns about healthcare costs and small business hiring trends. The stock has a 60% chance of a slight decline (-1.58%) in the next day and a minor gain (2.64%) over the next month, suggesting limited upside.
In Q4 2025, revenue increased by 3.41% YoY to $1.668 billion. However, net income remains negative at -$33 million, despite a 266.67% improvement YoY. EPS is also negative at -0.87, though it improved by 262.50% YoY. Gross margin dropped significantly by 25.25% YoY to 9.59%, indicating profitability challenges.
Analysts have mixed views. Baird lowered the price target to $36 and maintains a Neutral rating. JPMorgan raised the price target to $35 but keeps an Underweight rating. Roth Capital lowered the price target to $56 but maintains a Buy rating, citing uncertainty in healthcare costs and hiring trends.
